Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPIRIT: Rivaroxaban and Aspirin in Carotid Plaque Inflammation
NCT05797376Phase 4Completed
- Sponsor
- Asan Medical Center
- Start
- Aug 2021
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rivaroxaban in atherosclerosis, coronary artery disease (CAD), Peripheral Arterial Disease (PAD), carotid artery stenosis, sponsored by Asan Medical Center. Started Aug 2021; status: completed.
02
Drugs
rivaroxaban
03
Conditions
atherosclerosiscoronary artery disease (CAD)Peripheral Arterial Disease (PAD)carotid artery stenosis
Beyond the preview
Go deeper on NCT05797376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05797376.